(Q33858898)

English

Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Chau-Ting Yeh

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Hui-Chin Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Chang-Mu Sung

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Cheng-Lung Hsu

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Chen-Chun Lin

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kuang-Tse Pan

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Jeng-Hwei Tseng

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Chien-Fu Hung

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

31 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

117

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-117

0 references

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

Recent evidence in the treatment of small hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

Metronomic dosing of chemotherapy: applications in pediatric oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

Hepatocellular carcinoma: epidemiology, risk factors, and screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

Estimating the world cancer burden: Globocan 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

Frequent integration of hepatitis B virus DNA in noncancerous liver tissue from hepatocellular carcinoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

Hepatitis B Virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: A Case‐Control study in Fukuoka, Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

5 July 2018

Expression of the HCRP1 mRNA in HCC as an independent predictor of disease-free survival after surgical resection

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-117

21 January 2018

Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-117

21 January 2018

Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-117

21 January 2018

Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-117

21 January 2018

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-117

21 January 2018

Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-117

21 January 2018

Median survival time of patients after transcatheter chemo-embolization for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3079691

29 October 2018

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/21453495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/21453495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter

1 reference

https://pubmed.ncbi.nlm.nih.gov/21453495

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-11-117

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33858898&oldid=1637371873"